Tal Goshen‐Lago

576 total citations
21 papers, 391 citations indexed

About

Tal Goshen‐Lago is a scholar working on Oncology, Infectious Diseases and Surgery. According to data from OpenAlex, Tal Goshen‐Lago has authored 21 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Tal Goshen‐Lago's work include Gastric Cancer Management and Outcomes (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Genetic factors in colorectal cancer (3 papers). Tal Goshen‐Lago is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Genetic factors in colorectal cancer (3 papers). Tal Goshen‐Lago collaborates with scholars based in Israel, United States and Singapore. Tal Goshen‐Lago's co-authors include Irit Ben‐Aharon, Michael Halberthal, Ronit Almog, Moran Szwarcwort‐Cohen, Anat Reiner‐Benaim, Avivit Peer, Khetam Hussein, Baruch Brenner, Yael Shachor‐Meyouhas and Yoram Reiter and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Tal Goshen‐Lago

21 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tal Goshen‐Lago Israel 10 200 127 106 77 53 21 391
Nesrine Mejri Tunisia 10 126 0.6× 38 0.3× 62 0.6× 36 0.5× 38 0.7× 51 317
Tumas Beinortas United Kingdom 6 97 0.5× 192 1.5× 63 0.6× 35 0.5× 23 0.4× 9 319
Ana S. Ferrigno Mexico 9 114 0.6× 81 0.6× 27 0.3× 43 0.6× 38 0.7× 40 279
Concepcion D. Arrastia United States 11 102 0.5× 32 0.3× 92 0.9× 87 1.1× 33 0.6× 15 482
Mónica Ballesteros Spain 10 109 0.5× 80 0.6× 78 0.7× 23 0.3× 23 0.4× 26 407
Adam Lee United States 8 92 0.5× 157 1.2× 29 0.3× 28 0.4× 85 1.6× 32 359
Deborah Enting United Kingdom 9 167 0.8× 39 0.3× 74 0.7× 203 2.6× 87 1.6× 42 374
Jalpa Shah United States 7 152 0.8× 38 0.3× 209 2.0× 15 0.2× 49 0.9× 16 400
Kate Lathrop United States 9 171 0.9× 128 1.0× 39 0.4× 11 0.1× 57 1.1× 25 284
Alberto Ranghiero Italy 12 102 0.5× 34 0.3× 91 0.9× 17 0.2× 60 1.1× 28 296

Countries citing papers authored by Tal Goshen‐Lago

Since Specialization
Citations

This map shows the geographic impact of Tal Goshen‐Lago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Goshen‐Lago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Goshen‐Lago more than expected).

Fields of papers citing papers by Tal Goshen‐Lago

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Goshen‐Lago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Goshen‐Lago. The network helps show where Tal Goshen‐Lago may publish in the future.

Co-authorship network of co-authors of Tal Goshen‐Lago

This figure shows the co-authorship network connecting the top 25 collaborators of Tal Goshen‐Lago. A scholar is included among the top collaborators of Tal Goshen‐Lago based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tal Goshen‐Lago. Tal Goshen‐Lago is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ben‐Aharon, Irit, Ran S. Rotem, Cheli Melzer Cohen, et al.. (2023). Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study. JMIR Public Health and Surveillance. 9. e50110–e50110. 4 indexed citations
2.
Haddad, Riad, Tal Goshen‐Lago, Mattan Levi, et al.. (2022). Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma. Journal of Personalized Medicine. 12(4). 627–627. 7 indexed citations
3.
Goshen‐Lago, Tal, et al.. (2022). Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors. JAMA Oncology. 8(6). 940–940. 1 indexed citations
4.
Pevsner‐Fischer, Meirav, Tal Goshen‐Lago, Judith Diment, et al.. (2021). Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles. Cancer Research. 81(7). 1639–1653. 71 indexed citations
5.
Goshen‐Lago, Tal, Moran Szwarcwort‐Cohen, Anat Reiner‐Benaim, et al.. (2021). Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors. Cancer Discovery. 11(10). 2430–2435. 37 indexed citations
6.
Goshen‐Lago, Tal, Riad Haddad, Baruch Brenner, et al.. (2021). Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer. Cancer Reports. 5(3). e1489–e1489. 3 indexed citations
7.
Elitzur, Sarah, Tal Goshen‐Lago, Gil Gilad, et al.. (2021). Long-term ovarian reserve and fertility outcomes in female survivors of childhood acute lymphoblastic leukemia. Leukemia & lymphoma. 62(9). 2211–2218. 4 indexed citations
8.
Goshen‐Lago, Tal, Moran Szwarcwort‐Cohen, Anat Reiner‐Benaim, et al.. (2021). Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer. JAMA Oncology. 7(10). 1507–1507. 102 indexed citations
9.
Ross, Jeffrey S., Tal Goshen‐Lago, Riad Haddad, et al.. (2020). ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway. Oncology Research and Treatment. 44(1-2). 20–27. 22 indexed citations
10.
Bar‐Joseph, Hadas, Fedro A. Peccatori, Tal Goshen‐Lago, et al.. (2020). Cancer During Pregnancy: The Role of Vascular Toxicity in Chemotherapy-Induced Placental Toxicity. Cancers. 12(5). 1277–1277. 8 indexed citations
11.
Ben‐Aharon, Irit, Tal Goshen‐Lago, Ilit Turgeman, et al.. (2020). Young patients with cancer and a digital social network: the voice beyond the clinic. ESMO Open. 5(3). e000651–e000651. 11 indexed citations
12.
Moore, Assaf, Tal Goshen‐Lago, Sara Morgenstern, et al.. (2020). Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?. BMC Cancer. 20(1). 34–34. 24 indexed citations
13.
Goshen‐Lago, Tal, Moran Szwarcwort‐Cohen, Madeleine Benguigui, et al.. (2020). The Potential Role of Immune Alteration in the Cancer–COVID19 Equation—A Prospective Longitudinal Study. Cancers. 12(9). 2421–2421. 9 indexed citations
14.
Levi, Mattan, Tal Goshen‐Lago, Rinat Yerushalmi, et al.. (2020). Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside. Biomedicines. 8(12). 577–577. 12 indexed citations
15.
Ben‐Aharon, Irit, Tal Goshen‐Lago, Elisa Fontana, et al.. (2019). Social networks for young patients with cancer: the time for system agility. The Lancet Oncology. 20(6). 765–765. 9 indexed citations
16.
Ben‐Aharon, Irit, Tal Goshen‐Lago, Sara Morgenstern, et al.. (2019). Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location. The Oncologist. 24(8). e696–e701. 8 indexed citations
17.
Ben‐Aharon, Irit, Tal Goshen‐Lago, Ravit Geva, et al.. (2017). Sidedness matters: Surrogate biomarkers prognosticate colorectal cancer upon anatomic location.. Journal of Clinical Oncology. 35(4_suppl). 523–523. 1 indexed citations
18.
Goshen‐Lago, Tal, et al.. (2016). Isolation and Characterization of Intrinsically Active (MEK-Independent) Mutants of Mpk1/Erk. Methods in molecular biology. 1487. 65–88. 3 indexed citations
19.
Goshen‐Lago, Tal, et al.. (2016). Variants of the yeast MAPK Mpk1 are fully functional independently of activation loop phosphorylation. Molecular Biology of the Cell. 27(17). 2771–2783. 10 indexed citations
20.
Goshen‐Lago, Tal, Alexei Shir, Jonah Beenstock, et al.. (2015). Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation. Molecular Biology of the Cell. 27(6). 1026–1039. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nesrine Mejri Breakdown of academic impact, for papers by Tumas Beinortas Breakdown of academic impact, for papers by Ana S. Ferrigno Breakdown of academic impact, for papers by Concepcion D. Arrastia Breakdown of academic impact, for papers by Mónica Ballesteros Breakdown of academic impact, for papers by Adam Lee Breakdown of academic impact, for papers by Deborah Enting Breakdown of academic impact, for papers by Jalpa Shah Breakdown of academic impact, for papers by Kate Lathrop Breakdown of academic impact, for papers by Alberto Ranghiero
Rankless by CCL
2026